As a seedholder, about the only thing that keeps me sane and mildly hopeful, is that the director keeps buying shares. Trying very hard to remain patient though.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
